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Abstract
Circadian rhythms are recurring near-24 hour patterns driven by an endogenous circadian timekeeping system. The master
pacemaker in this system is the hypothalamic suprachiasmatic nucleus (SCN). Recently interest has been drawn to how the
SCN clock responds to immune system stimulation. A major signalling component in the immune system is nuclear factor
(NF)-jB. In the present study we examined the role of NF-jB in SCN function. Whilst serum shocked fibroblasts showed
rhythmic nuclear localisation of p65 and p65-dependent transcription, there were no circadian changes in the SCN in expres-
sion of the NF-jB components p65, c-Rel, p-IjB or p-IKK. Chronic treatment with the NF-jB inhibitor PDTC did not impact
on circadian or diurnal rhythms. Phase-shifting light pulses did not impact on SCN expression of p65, and PDTC treatment
did not attenuate the behavioural or molecular response to light pulses. Peripheral treatment with lipopolysaccharide resulted
in increased NF-jB component expression in the SCN. In vitro experiments with SCN slice cultures showed that treatment
with NF-jB inhibitors did not markedly alter rhythmic changes in PER2::LUC expression. Further, SCN slices from nf-jb::luc
mice did not show any evidence for circadian rhythms in NF-jB-mediated transcription. Experiments utilising older mice
(~16 months old) showed that SCN treatment in vitro with PDTC resulted in increased amplitude of rhythmic PER2::LUC
expression, and LPS treatment resulted in altered PER2::LUC rhythm acrophase. Overall, we interpret our results as provid-
ing evidence for the involvement of NF-jB in the suprachiasmatic circadian clock following immune stimulation, but not under
basal conditions.
Introduction
Circadian rhythms are recurring patterns in physiological, biochemi-
cal, metabolic, behavioural or other parameters that cycle approxi-
mately every 24 h and persist in the absence of external time cues
(Reppert & Weaver, 2002). Such internally generated rhythms are
the products of a complex circadian timing system, with a master
pacemaker located in the suprachiasmatic nuclei (SCN) of the ante-
rior hypothalamus synchronising semi-autonomous circadian pace-
makers throughout the CNS and the periphery in order to impose a
daily temporal architecture on mammalian physiology and behaviour
(Antle & Silver, 2005). These circadian rhythms are in turn nor-
mally entrained to appropriate environmental signals (zeitgebers),
the principal one being light (Golombek & Rosenstein, 2010). There
is a direct glutamatergic innervation of the SCN arising from a sub-
set of intrinsically photosensitive retinal ganglion cells that express
the photopigment melanopsin that convey photic information to the
SCN (Lucas et al., 2014). At a molecular level, the workings of the
circadian clock comprises a series of interlocking feedback/feedfor-
ward transcriptional loops whose core components are a panel of
canonical clock genes and their protein products (Albrecht, 2012).
These clock genes in turn regulate the temporal expression of a wide
range of clock-controlled genes in a tissue specific manner (Zhang
et al., 2014), and such regulation is ultimately translated into physi-
ological and behavioural rhythms.
An area of considerable research in previous years addresses the
signalling input pathways that convey events at the SCN neuronal
membrane (such as ligand-receptor binding events) to the core
nuclear clockworks. To date several signalling pathways have been
identified as playing such key roles, including those involving mito-
gen activated protein kinases (Coogan & Piggins, 2004), protein
kinase C (Bonsall & Lall, 2013) and salt-inducible kinase 1 (Jagan-
nath et al., 2013). These signallers are believed to alter the activity
of transcriptions factors such as CREB, which then bind to promoter
sequences on clock genes to alter their expression (Lee et al.,
2010). One pathway that has not been systemically investigated in
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terms of regulation of suprachiasmatic clock function involves the
transcription factor nuclear factor–jB (NF-jB) pathway. NF-jB is
composed of dimers of members of the Rel family, including p50,
p52, p65 (also known as RelA), c-Rel and Rel-B, with p65-p50
being the most common dimeric complex (Ghosh & Hayden, 2012).
Under basal condition, NF-jB component proteins are held in the
cytoplasm in complex with members of the inhibitor IjB protein
family. When bound to IjBs, one nuclear localisation signal on NF-
jB components is obscured. Upon activation, IjB is phosphory-
lated, then ubiquitinated and finally proteolysed, allowing NF-jB
dimers free access to the nucleus to regulate transcription of genes
containing j-B binding sites (Moynagh, 2005). NF-jB has been
shown to be activated following ligand binding to Toll-like receptors
(TLRs), and receptors for the pro-inflammatory cytokines inter-
leukin-1 and tumour necrosis factor (TNF), amongst others (Lawr-
ence, 2009). Although originally described in the peripheral immune
system, NF-jB has been implicated in CNS function, with roles
described in synaptic plasticity, neurogenesis and learning and mem-
ory (Crampton & O’Keeffe, 2013; Snow et al., 2014; Kaltschmidt
& Kaltschmidt, 2015), as well as its better defined roles in neuroin-
flammation and neurodegeneration (Malek et al., 2007). However,
recent studies have raised questions as to whether NF-jB activity is
constitutive in young adult neurons in the basal state (Herkenham
et al., 2011; Listwak et al., 2013; Zhang et al., 2013), indicating
that activity in glia or endothelia may be linked to CNS processes
linked to NK-jB activity.
Given that stimulation of the peripheral immune system can alter
circadian timing (e.g. Marpegan et al., 2004; Coogan & Wyse,
2008; Paladino et al., 2014), and that the SCN appears to be
responsive to such stimulation (Beynon & Coogan, 2010), it is of
interest to ask the role that NF-jB signalling might play in the
SCN circadian clock and resetting of circadian rhythms. One study
in hamsters indicated that NF-jB signalling was involved in photic
resetting of behavioural rhythms (Marpegan et al., 2004). Previous
studies in peripheral cell types have indicated that NF-jB interacts
with core clock gene products (Bellet et al., 2012; Narasimamurthy
et al., 2012; Spengler et al., 2012; Curtis et al., 2015), although
given the differences in neuronal expression it is not clear whether
such interactions may occur in the master SCN clock. In order to
address this we have carried out a study in which we examined
the expression of NF-jB pathway components in the SCN across
the circadian cycle and following photic and immune stimulation,
as well as examining the consequences of pharmacological block-
ade of the NF-jB pathway on circadian rhythms in vivo and
in vitro.
Materials and methods
Fibroblast cell culture and serum shock
The immortalised mouse fibroblast NIH/3T3 cell line was cultured
in Dulbecco’s Modified Eagle medium (DMEM) with Glutamax-1,
4.5 g/L D-Glucose and pyruvate (Gibco, UK) supplemented with
10% foetal bovine serum (FBS) (Gibco) and 1% penicillin-strepto-
mycin (Gibco). All medium was pre-warmed to 37 °C. After reach-
ing 80% confluency (approximately every 3 days), the cells were
passaged by washing with phosphate – buffered saline (Gibco) and
then exposed to a 5 min incubation with Trypsin-EDTA solution
(0.5 g/L trypsin and 0.2 g/L EDTA in PBS) until cells became
detached. Trypsin was deactivated with DMEM and cells re-sus-
pended vigorously so a single cell suspension was achieved. Cells
were then transferred to a 75 cm2 tissue culture flask containing
fresh cell culture medium at a 1 : 10 dilution. Serum shock experi-
ments were carried out according to the protocol by Balsalobre
et al. (1998). NIH/3T3 cells in log phase growth were washed with
PBS, trypsinised and resuspended in10% DMEM and seeded into
culture dishes at a density of 1 9 105 10 cm2. Upon reaching con-
fluency medium was replaced with serum rich medium [DMEM
supplemented with 50% Horse serum (GIBCO)] time = 0 and after
2-h incubation medium was replaced with serum free DMEM.
Nuclear and Cytoplasmic protein extractions were performed every
4 h up to 72 h after serum treatment using a Nuclear Extract Kit
(Active Motif, Belgium). For sham shocked controls, serum free
cells NIH/3T3 cells were seeded into culture dishes at a density of
1 9 105 10 cm2 in 10%DMEM and upon reaching confluency
media was replaced with serum free DMEM (time = 0) and subse-
quent nuclear and cytoplasmic extractions undertaken every 4 h for
48 h using Active Motifs Nuclear Extract Kit.
Western blotting
Protein concentrations in cytoplasmic and nuclear fractions were
determined using a detergent compatible protein assay kit, DC Pro-
tein Assay (Bio-Rad Laboratories, UK). Lysates were mixed with
Laemmli Lysis Buffer (Sigma, UK) in a 1 : 1 ratio at a concentra-
tion of 5 lg protein and incubated for 5 min at 95–100 °C in a heat
block. Samples were briefly spun down and proteins in the extract
were separated by gel electrophoresis using an 8 or 10% sodium
dodecyl sulphate-polyacrylamide gel (SDS-PAGE), depending on
the size of the protein being detected. Five microlitre of precision
plus protein all blue standard (Bio-Rad Laboratories) was loaded
into the gel system as a protein marker. Following this Immun-Blot
polyvinylidene fluoride (PVDF) membranes (Bio-Rad) were
immersed in 100% methanol, and incubated with fibre pads, blot
paper (Bio-Rad) and polyacrylamide gels, for 15 min in transfer
buffer pre-cooled to 4 °C. Proteins were electrotransferred onto the
membrane using Trans-blot system (Bio-Rad, UK) at 400 mA for
1 h at 4 °C. After transfer the membranes (blots) were washed with
TBS/T (Tris Buffered Saline containing 0.1% (v/v) Tween 20) for
5 min and non-specific binding was blocked by exposing the mem-
branes to 3% dry milk (1.5 g milk and 50 mL TBS/T; Sigma), for
1 h at room temperature with mild agitation. Subsequent washes
with TBS/T for 5 min were followed by incubation with primary
antibody for 90 min at room temperature with mild agitation. The
primary antibodies used in this experiment were p65 subunit of the
NF-KB complex (sc-372, used at 1 : 1000, rabbit polyclonal; Santa
Cruz Biotechnology, USA) and the nuclear matrix protein p84
(mouse monoclonal; abcam, UK, ab487, used at 1 : 1000) used as a
nuclear marker and loading control. Membranes (blots) were washed
2 9 10 min with TBS/T then incubated with horseradish peroxi-
dase-conjugated secondary antibody (goat polyclonal to rabbit IgG;
abcam, ab6721, used at 1 : 2000 and rabbit polyclonal to mouse
IgG; abcam, ab6728, used at 1 : 5000) for 45 min at room tempera-
ture with mild agitation. Membranes were subsequently washed
3 9 10 min with TBS/T. For protein detection peroxide solution
and luminol/enhancer solution (Immun-star WesternC Chemilumi-
nescent kit; Bio-Rad, UK) were mixed in a 1 : 1 ratio and incubated
for 5 min at room temperature with gentle agitation. The proteins
were visualised using ChemiDoc XRS (Bio-Rad) after 15 s to a 2-
min exposure. Protein banding was densitometrically assessed using
the Scion Image _ 4.2 software (Scion Corporation, MA, USA).
Stain density of bands was analysed by measurement of the uncali-
brated optical density [OD = log10(255/(255 – grey value, where
the grey value is calculated for each pixel in the selection and score
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0–255))]. All values of target proteins were normalised to a standard
nuclear matrix protein p84 followed by normalisation to control.
NF-jB p65 transcription factor assay
Nuclear extract samples were diluted in 20 lL of complete lysis
buffer at a concentration of 5 lg. Thirty microlitre of Complete
Binding Buffer was added to each well (containing an oligonu-
cleotide with the NF-KB consensus site 50 –GGACTTTCC-30 immo-
bilised to it) followed by 20 lL of sample diluted in complete lysis
buffer, a blank (20 lL complete lysis buffer only) and a positive
control Jurkat Nuclear extract (Active Motif, Belgium) were also
added all in duplicate. The plate was then incubated for 1 h at room
temperature (RT) with mild agitation (150 rpm on a rocking plat-
form) and covered with an adhesive seal. Each well was subse-
quently washed three times with 200 lL 19 wash buffer. 100 lL of
diluted NFKB primary antibody (1 : 1000 dilution in 19 antibody
binding buffer) was added to each well and the plate covered and
incubated for 1 h at RT without agitation. Wells were washed three
times with 200 lL 19 wash buffer as previously described. This is
followed by the addition of 100 lL of diluted HRP-conjugated sec-
ondary antibody (1 : 1000 dilution in 19 antibody binding buffer)
for 1 h at RT without agitation. The wells were washed four times
with 200 lL 19 wash buffer as described previously and 100 lL of
pre-warmed developing solution added. The plate was incubated for
2 min at RT away from direct sunlight until the samples turned to a
medium to dark blue. 100 lL of stop solution was added, which in
the presence of acid turns the blue colour yellow and absorbance
was read at 460 nm on POLARstar OMEGA plate reader (BMG
labtech, Germany).
Behavioural circadian rhythm monitoring
Male C57Bl/6 mice (8–14 weeks old) obtained from Charles River
Laboratories (Kent, UK) were used throughout this study apart from
experiments for luciferase-reporter analysis (detailed below). All
experiments were approved by the Research Ethics Committee,
National University of Ireland Maynooth and licensed by the Irish
Department of Health and Children and were carried out in accor-
dance with European Union directive 2010/63. In total, 304 mice
were used in this study. Animals were housed in a conventional
facility, and as such were not specific pathogen free.
For the analysis of circadian wheel running behaviour, animals
were singly housed in polypropylene cages equipped with running
wheels (11 cm diameter) with food and water available ad libitum
and temperature held constant at 21 + 1 °C and humidity at
50 + 10%. Cages were then housed in an environmental isolation
cabinet to allow for full control of the photic environment. Illumina-
tion was via a white light fluorescent source, with average illumi-
nance at the level of the cage floor of 250 lux when lights were on.
Bedding was changed every 14 days, and never in the period lead-
ing up to or after a pharmacological intervention. Wheel running
was monitored via microswitches attached to the running wheels
communicating with the Chronobiology Kit (Stanford Software Sys-
tems, CA, USA) to allow for production of actograms of wheel-run-
ning behaviour. Prior to any pharmacological intervention animals
were allowed to free-run for 2 weeks to allow for analysis of stable
baselines of circadian factors. Phase-shifts were rated by two to
three independent observers blind to the treatments by means of the
line-of-best-fit method through activity onsets for 10 days prior to
and after any intervention. Phase shifts were calculated as the differ-
ence in the regression lines before and after the intervention,
calculated on the day following the intervention. Period length and
rhythm strength were obtained from Poisson Periodograms in the
Chronobiology kit.
For experiments examining the photic induction of NF-jB com-
ponents in the SCN, animals were group housed in cages of five
under a 12 : 12 light : dark cycle before being transferred into con-
stant darkness (DD) for two cycles, with light pulses delivered at
CT15 (for this case 3 h after when the lights were going out in the
colony under the previous LD cycle) or at CT22 for 30 min (150
lux). Animals were sampled prior to the light pulse, 5 or 30 min
into the light pulse, or 30 min after the completion of the light
pulse. For circadian analysis of NF-jB in the SCN, group housed
animals were entrained to a 12 : 12 light : dark cycle prior to being
released into DD and sampled every 4 h for 24 h on the third cycle
of DD. For these experiments animals were sampled in DD under
dim red light.
In vivo drug treatments
We utilised pyrrolidine dithiocarbamate (PDTC) as an inhibitor of
NF-jB activity for in vivo experiments. PDTC is a blood-brain bar-
rier permeant molecule that appears to have a number of modes of
action in preventing NF-kB activation, including inhibition of IjB
ubiquitin ligase activity (Nurmi et al., 2004; Gupta et al., 2010; Li
et al., 2012). PDTC is also an anti-oxidant and metal chelator,
although it appears that it’s NF-kB inhibitory action is independent
of its action as an anti-oxidant (Hayakawya et al., 2003). For beha-
vioural analysis of phase shifts, single housed animals were initially
entrained to a 12 : 12 light : dark cycles before being released into
DD for 14 days. Animals then received an i.p. injection of PDTC
(200 mg/kg; Sigma, Ireland; Anderson et al., 2015b) or vehicle (1%
DMSO in saline) at either CT14.5 or CT21.5. They were then
exposed to a 30 min light pulse before being placed back in DD.
14 days after the first treatment animals were treated with the cross-
over treatment and light-pulsed at the same CT as in the first treat-
ment. For experiments utilising sub-chronic treatment with PDTC,
PDTC (50 mg/kg/day; Ahtoniemi et al., 2007) or vehicle (1%
DMSO) was delivered via the drinking water for 14 days under a
12 : 12 light : dark cycle, and for another 14 days after animals
were transferred into DD. PDTC or vehicle was renewed every
3 days. Daily doses were calculated on the basis of previously deter-
mined daily drinking water intake for individual animals. Treatment
was then crossed over (vehicle to PDTC, or vice versa) and for a
further 14 days in DD followed by 14 days following being placed
back into the original L : D cycle. Water and drug were renewed
every 3 days throughout this experiment. For experiments involving
LPS treatment, animals received a single i.p. injection of 5 mg/kg
LPS (serotype 0111.B4; Sigma) or sterile saline vehicle which
occurred between zeitgeber time (ZT) 6 and ZT8, where ZT0 is
defined as the time of lights on. Animals were sampled 24 h after
the LPS treatment.
Immunohistochemistry
For immunohistochemical analysis of brain, animals were termi-
nally anaesthetised with 0.1 mL sodium pentobarbitone and per-
fused transcardially with 0.9% saline followed by 4%
paraformaldehyde in 0.1 M Phosphate Buffer. Brains were subse-
quently removed, post-fixed overnight and cryoprotected in 30%
Sucrose (Sigma) for 24 h. 30 lm thick serial coronal sections were
cut throughout the rostrocaudal extent of the SCN on a freezing
stage microtome (Leica). All sections through the SCN were
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collected and divided in four series, obtaining five or six sections
through the SCN in each series. Immunohistochemistry was by a
standard Avidin-Biotin Complex/Nickel DAB colourimetric proto-
col, as previously described (Beynon et al., 2009). A list of all of
the primary antibodies used in this study is in Table S1. Lack of
non-specific staining was confirmed by pre-incubation with pep-
tides used to raise the primary antibodies. As much as feasible sec-
tions for the same antigen from different groups were reacted in
parallel, and when this was not possible development of immunos-
taining was standardised between runs (e.g. same amount of time
developing in Ni-DAB) to minimise as much as possible inter-run
variability. For analysis of immunostained sections photomicro-
graphs of the mid-rostrocaudal level of the SCN were taken using
a digital camera connected to an Olympus BX-51 light microscope
equipped with an image analysis digital system (ImageJ 1.43; NIH,
USA). Between three and six images were evaluated for each indi-
vidual animal and region to give a mean value for each animal.
Immunoreactive cells in each region of interest were quantified
using either image analysis software or number of immunoreactive
cells quantified by an observer (for immediate early genes). The
observer was blinded to the experimental procedure during optical
density measurements or quantification of immunoreactive cells per
SCN. The difference in integrated optical density (IOD) of anti-
body immunosignal in the SCN or the number of immunoreactive
cells that displayed clear nuclear staining in the SCN of all animal
groups was evaluated for quantitative analysis. p65, as part of the
NF-jB complex, when activated translocates to the nucleus and as
such we quantified the number of cells that displayed clear nuclear
p65 staining as well as quantitating the IOD for p65 immunostain-
ing (Beynon & Coogan, 2010). The light intensity was kept con-
stant while all measurements were taken to standardise IOD
measurements for analysis.
SCN PER2::LUC and nf-jb::luc in vitro monitoring
Expression of PER2 or NF-jB-mediated transcription was monitored
in the SCN in vivo with the use of luciferase-based reporter con-
structs expressed in transgenic mice. For PER2::LUC monitoring we
utilised a knock-in mouse line which expresses a PER2-LUC fusion
protein (Yoo et al., 2004). NF-jB-mediated transcription was moni-
tored with the use of a transgenic line in which luciferase transcrip-
tion is driven by a promoter sequence containing two NF-jB
binding sites in front of a minimal fos promoter (Voll et al., 2000).
Both lines were obtained from The Jackson Laboratory (Maine,
USA). PER2::LUC animals were maintained as homozygotes and
nf-jB::luc animals as hemizygotes. Both lines were on a C57Bl/6
background and both male and female mice were used for slice
preparation.
For SCN slice culture preparation, a protocol as previously
described was followed (Hastings et al., 2005). Briefly, mice were
culled by cervical dislocation following halothane anaesthesia during
the mid lights on period (ZT6-ZT8). Brains were rapidly removed
and ice cooled before coronal 300 lm thick hypothalamic slices
containing the SCN were prepared using a Vibroslice (Campden
Insturments, UK). The SCN was then microdissected out under ster-
ile conditions and transferred to interface-style Millicell culture
inserts (Millipore, Ireland) placed in culture dishes sealed with a
glass cover slip and containing 1.2 mL of sterile culture medium
(DMEM supplemented with 3.5 g/L d-glucose, 0.035% sodium
bicarbonate, 0.01 M HEPES buffer (all Sigma), 1000 lg/mL peni-
cillin–streptomycin and 5% foetal bovine serum (both Gibco Invitro-
gen Ltd). Culture dishes were then placed in a light-tight incubator
at 37 °C, with each individual culture placed under a photomulti-
plier tube (PMT) assemblies (H8259/R7518P; Hamamatsu, UK).
Photon counts were integrated for 59 s every 1 min. Biolumines-
cence data were detrended offline by subtracting a 24 h running
average from the raw data and smoothed with a 3 h running average
(Guilding et al., 2010). For drug treatments of PER2::LUC slices
with NF-jB pathway inhibitors, PDTC (20 lm in 0.01% vehicle
DMSO) or sulfasalazine [10 lm in 0.01% DMSO; Sulfasalazine
inhibits NF-jB activation through blocking IjB kinase activity
(Weber et al., 2000)], or LPS as a NF-jB activator (100 ng/mL),
were applied upon culture preparation and left in the culture medium
for the duration of the recording.
Statistical analysis
Statistical analysis was carried out on SPSS (www.spss.com) on a
PC. As appropriate to the individual experiment, data was either
analysed via one-way ANOVA, between groups two-way ANOVA,
between-within mixed ANOVAs, between groups t-tests, and paired
t-tests as appropriate to the experimental design and data. Post hoc
analysis of pairwise differences was via the Tukey HSD test.
Assessment of circadian rhythmicity in independent samples (e.g.
serum shocked fibroblasts, SCN examined by immunohistochem-
istry) was by CIRCWAVE V1.4 software (CircWave V1.4 by Hut,
2007, Groningen, The Netherlands) where peak phase and amplitude
were assessed and a significant rhythm was deemed to be presented
if the 95% confidence interval of the fitted curve’s amplitude did
not include 0. Circadian rhythmicity in PER2::LUC and nf-jb::luc
was assessed with the Acro and Cosinor programmes (http://www.c
ircadian.org/softwar.html).
Results
To initially gauge whether there may be an involvement of NF-jB
signalling in the circadian system, we examined serum shocked
fibroblasts, a well characterised cellular model of peripheral clocks.
Here we found that serum shocked, but not sham treated cells,
showed a significant circadian rhythm in the nuclear expression of
p65 protein over 48 h (P = 0.008 via cosinor analysis for shocked
cells; Fig. 1A). When we examined p65 driven transcriptional activ-
ity in these cells we also found there to be a significant rhythm in
the serum shocked cells (P = 0.009 via cosinor analysis), but also
found a significant rhythm in the sham treated cells (P = 0.01;
Fig. 1B).
Given these initial observations we then examined expression of
components of the NF-jB pathway in the SCN of mice in DD. We
found that p65 expression, as measured either as optical density of
the immunostaining (Fig. 2A) or as number of cells clearly express-
ing nuclear p65 (data not shown), did not vary with time in the
SCN (F5,12 = 1.23, P = 0.35 via one-way ANOVA). Likewise, c-Rel-
immunoreactivity also did not vary with time in the SCN
(F5,12 = 0.89, P = 0.53; Fig. 2B). We then examined two upstream
components of the pathway, phosphorylated-IKK and phosphory-
lated-IjB, and find that expression of these factors do not vary with
time in the SCN (F5,12 = 1.22, P = 0.35; F5,12 = 0.21, P = 0.95
respectively, Fig. 2C and D). Further, none of these four antigens
showed evidence of circadian rhythmicity as judged by co-sinor
analysis. As a positive control, the clock gene product PER1
showed statistically significant cycling as expected in the SCN
(Fig. S1).
To further investigate whether the NF-jB pathway may place a
role in the ongoing running of the central circadian clock, mice were
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treated with vehicle and the NF-jB inhibitor PDTC chronically via
drinking water under conditions of both LD and DD (Fig. 3A).
Analysis of the locomotor rhythms under both LD and DD revealed
no significant differences between vehicle and PDTC treatment:
under LD, the phase angle of entrainment was not altered (Fig. 3B;
P = 0.53 between vehicle and PDTC treatment via paired t-test). In
Fig. 1. Expression of p65 in the nuclear fraction of serum shocked (A) or sham-shocked (B) fibroblast over a 48 h time course after shock. (C) and (D) show
the data for p65-dependent transcription. The dotted line shows the cosine wave of best significant fit (with a 12 h harmonic for A and D). Serum shocked cells
show a significant circadian rhythm in expression, but sham-shocked cells do not (A and B). For p65 driven transcriptional activity there was circadian rhyth-
micity, as judged by co-sinor analysis, in both serum shocked (C) and sham-shocked cells (D). [Colour figure can be viewed at wileyonlinelibrary.com].
Fig. 2. Expression of p65 (A), cRel (B), p-IkB (C) and p-IKK (D) in the SCN across the circadian cycle from animals sampled in DD. N = 3–4 per time-point.
There was no significant effect of time for SCN expression of any of these antigens. The scale bar on the photomicrographs represent 100 lm.
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DD the period and rhythm power were not altered (Fig. 3B;
P = 0.52 and P = 0.52 respectively between vehicle and PDTC
treatment). We then examined the SCNs of animals treated with
either PDTC or vehicle for their expression of p65, c-Fos and PER1
at ZT6 and ZT12 (Fig. 3C). These two time-points were chosen as
they represent when the peak (ZT12) and near nadir (ZT6) of PER1
expression would be expected under a 12 : 12 L : D cycle (see
Field et al., 2000; and also Fig. S1 which shows the rhythmic
expression of PER1 in the SCN in DD in our experiments). We
found that there was no significant effect of drug treatment
(F1,15 = 0.667, P = 0.431; F1,13 = 0.600, P = 0.485; F1,16 = 2.39,
P = 0.147 respectively for p65, c-Fos and PER1), nor any signifi-
cant drug x time-point interaction for any of the three antigens
(F1,15 = 0.667, P = 0.431; F1,13 = 0.600, P = 0.485; F1,16 = 2.39,
P = 0.147 respectively for p65, c-Fos and PER1). These results
appear to indicate that the NF-jB pathway is not involved in the
free-running of the SCN clock in vivo.
We next examined the role the NF-jB pathway may play in pho-
tic resetting of the SCN clock. We examined whether the NF-jB
inhibitor PDTC would alter the phase-resetting effects of light. Ani-
mals were pre-treated with PDTC or vehicle 30 min prior to the pre-
sentation of a light pulse at CT15 or CT22. It was found that
treatment with PDTC did not impact on the magnitude of the phase
shifts elicited by a phase-delaying or -advancing light pulse
(P = 0.085 and P = 0.77) via paired t-tests respectively for CT15
and CT22; Fig. 4A, B). We then examined the SCN for expression
Fig. 3. Treatment with the NF-jB inhibitor PDTC does not impact on behavioural circadian wheel running rhythms. (A) Sample actogram showing the effects
of PDTC (via drinking water at a dose of 50 mg/kg/day) and vehicle treatment on behavioural rhythms under light : dark (LD) and constant darkness (DD) con-
ditions, where shading on the actogram indicates darkness; (B) Boxplots showing the effects of PDTC on phase angle of entrainment under LD, free running
period in DD, and rhythm power in DD. There were no statistically significant differences in any of these measures between PDTC and vehicle treated
(N = 16); (C) Effect of previous PDTC vs. vehicle treatment, shown as boxplots, on expression of p65, c-Fos and PER1 in the SCN during the lights-on phase
(ZT6) and the start of lights-off phase (ZT12; chosen as this is the peak of PER1 expression in the SCN). There were no statistically significant effects of treat-
ment or time x treatment interactions for these three antigens. N = 4 per group.
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of p65 after light-pulses at both CT15 and CT22. No change in p65
was found at 5, 30 or 60 min after the onset of the light pulse at
either circadian phase (Fig. 4C and D; P = 0.085 and P = 0.078 via
paired t-tests respectively for CT15 and CT22), although we con-
firmed that c-Fos-immunoreactivity was increased by these light
pulses, as expected (data not shown). We then examined the effect
of PDTC treatment on photic-induction of the immediate early genes
c-Fos and ARC in the SCN after a light pulse at CT22 (these IEGs
are induced in the SCN by photic stimulation during the subjective
night; Kornhauser et al., 1990; Nishimura et al., 2003). We found
that PDTC treatment had no effect on the magnitude of expression
of either factors 1 h after the light pulse (P = 0.13 and P = 0.37
respectively for c-Fos and ARC induction via independent t-tests;
Fig. 4D).
Having so far failed to find evidence for NF-jB involvement in
the normal function of the SCN clock, we then examined whether
there may be a role for NF-jB in mediating the circadian effects of
peripheral immune challenge. Firstly we challenged animals with a
5 mg/kg dose of LPS and sampled the SCN 24 h later (Beynon &
Coogan, 2010 demonstrated SCN responsivity at 24 h, but not 6 h
following such a treatment). We found that LPS elicited a significant
upregulation of p65 and p-IjB, and the IEG EGR-1 (P = 0.036,
P = 0.024 and P = 0.026 respectively via independent t-test;
Fig. 5A). c-Fos was also significantly upregulated by LPS challenge
(data not shown), but c-Rel was not. We then examined whether
there was a time-of-treatment effect of treatment on LPS-induced
changes in the SCN, and to this end we treated animals with LPS
(5 mg/kg) at either ZT6 or ZT18, sampling 24 h later. We find a
significant main effect of treatment on p65 (F1,17 = 6.55,
P = 0.024), but no time x treatment interaction (F1,17 = 0.523,
P = 0.483). For p-IjB there was no significant effect of treatment
on p-IjB (F1,16 = 2.61, P = 0.132), nor was there a significant time
x treatment interaction (F1,16 = 0.21, P = 0.654; Fig. 5B).
Given that 5 mg/kg of LPS represents a substantial dose that elic-
its systemic inflammation, we examined the effects of treatment with
LPS at a dose of 100 lg/kg given at CT15 to animals maintained in
DD. We used this treatment as previous data has shown that such
treatment elicits moderate phase-delays of the behavioural rhythm
(Marpegan et al., 2005; Anderson et al., 2015a). From behavioural
monitoring, we re-confirmed that LPS treatment at CT15 elicits a
small, but statistically significant, phase delay of the circadian loco-
motor rhythm (P = 0.011 between LPS and saline treatments via
paired t-test; Fig. 6A). We then examined effect of 100 lg/kg LPS
treatment at CT15 on the SCN by sampling animals 4 h after treat-
ment. We find that this lower dose LPS treatment resulted in
increased p65 nuclear translocation (P = 0.043; Fig. 6B), but not
increased p-IjB expression in the SCN (P = 0.23; Fig. 6C). We
also report that the LPS treatment results in upregulation of c-Fos in
the SCN (especially in the dorsolateral shell; P = 0.02; Fig. 6D) but
exerted no effect on PER1 expression (P = 0.22; Fig. 6E).
To complement out in vivo findings, we undertook a series of
in vitro experiments utilising SCN slice cultures derived from
PER2::LUC mice. We found that incubation of slices with PDTC
(20 lM) did not alter the phase, period or amplitude of the rhythm
of PER2::LUC (P = 0.79, P = 0.93 and P = 0.35 respectively)
expression, although the mesor of the rhythm was significantly ele-
vated in PDTC treated slices compared to vehicle control
(P = 0.001); Fig. 7A). Very similar results were found in slices trea-
ted with another NF-jB inhibitor, sulfasalazine (10 lM; Fig. 7B),
with no changes in rhythm period, acrophase or amplitude
(P = 0.94, P = 0.54 and P = 0.037, respectively), but there was
also not a statistically significant elevation in mesor in sulfasalazine
Fig. 4. Putative involvement of NF-jB in photic resetting of circadian rhythms. To examine whether acute inhibition of NF-jB would impact on subsequent
light-induced phase shifts, mice were treated with i.p. PDTC (or vehicle) 30 min prior to a light pulse at CT 15 (A) or CT22 (B). In both cases, PDTC treatment
was not associated with altered magnitude of phase shifts (N = 8 for each circadian phase; data shown as boxplots). Next the effect of light pulses on expression of
p65 in the SCN was examined. (C) Light pulses at CT15 and CT 22 were not followed by changes in p65 in the SCN (N = 3 per timepoint, data shown as box-
plots). (D) and (E) show the impact of PDTC treatment on light-induced expression of the immediate early genes c-Fos and ARC in the SCN at CT22. There was
no difference of saline vs. PDTC treatment on expression of either of these antigens (N = 4 per group). [Colour figure can be viewed at wileyonlinelibrary.com].
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treated slices compared to control (P = 0.07). In a further set of
slices, we utilised treatment with LPS (100 ng/mL) as an activator
of the NF-jB pathway. Slices treated with LPS did not show statis-
tically significant differences to vehicle treated slices in any of the
chronometrics examined (Fig. 7C; P = 0.53, P = 0.11, P = 0.13
and P = 0.12 for period, acrophase, amplitude and mesor respec-
tively). We then prepared SCN slices from nf-kb::luc mice and
examined the spontaneous expression of NF-kB-mediated transcrip-
tion across a number of days in culture. We find no evidence for
circadian modulation of NF-jB-mediated transcription (Fig. 7D and
E), although as a positive control we find that levels of NF-jB dri-
ven bioluminescence is higher in slices treated with LPS than vehi-
cle (P < 0.001; Fig. 7F).
As the experiments described above indicated that NF-jB sig-
nalling may not play core roles in regulating SCN function under
basal conditions in young animals, and given findings that NF-jB is
implicated in altered hypothalamic functioning with age (Zhang
et al., 2013), we undertook experiments in older animals
(~16 months) to examine any role for NF-jB in circadian function.
Behavioural rhythms in these animals showed that ageing was asso-
ciated with statistically significant decreased rhythm amplitude and
decreased total running (P = 0.04 and P = 0.01 respectively;
Fig. S2). When the SCN from these older animals was examined for
p65 expression at ZT6 and ZT18, 2-way ANOVA shows no significant
main effect of age (F1,17 = 0.283, P = 0.601) or time (F1,17 = 1.36,
P = 0.27), nor was there a significant interaction between age and
time (F1,17 = 1.07, P = 0.31; Fig. S2B). Next we examined the
reactivity of SCN p65 to LPS (5 mg/kg) treatment, and found that
LPS treatment resulted in a similar elevation of p65 compared to
control to what was previously observed in young animals
(P = 0.005 between LPS and saline treated groups). Finally, we pre-
pared SCN slices from aged PER2::luc animals (~16 months old)
and examined the effects of PDTC and LPS on bioluminescence
rhythms. We find that PDTC treatment of slices results in a signifi-
cant increase in rhythm amplitude and mesor (P = 0.036 and
P = 0.001 respectively; Fig. S3A), whilst LPS treatment does not
lead to significant changes in any chronometric (Fig. S3B).
Discussion
In this study we have examined what role the NF-jB pathway may
play in the regulation of the murine suprachiasmatic circadian clock.
We do not find evidence to support the contention that the NF-jB
pathway plays a role in the free-running SCN clock in vivo in
young, healthy animals, nor do we find evidence to support a role
in photic resetting of the clock. Further, we do not find evidence
that NF-jB plays a role in in vitro SCN clock function. However,
in accordance with previous reports, we do find evidence for the
neuroimmune regulation of NF-jB components in the SCN. There-
fore, there appears to be a distinction in the conditions under which
NF-jB signalling partakes in suprachiasmatic circadian function.
The role of NF-jB in circadian processes has previously been
indicated in studies of specific peripheral cell types. Spengler et al.
(2012) had previously demonstrated that the diurnal rhythm in
Fig. 5. Effects of LPS treatment on NF-jB component expression in the SCN. (A) Shows expression of p65, p-IjB, c-Rel and the immediate early gene
EGR1 in the SCN 24 h after a 5 mg/kg LPS challenge. LPS treatment upregulated expression of p65, p-IjB and EGR1 (*P < 0.05), but not c-Rel in the SCN
(n = 4–5 per group; data shown as boxplots). (B) and (C) show data from whether time-of-treatment (ZT6 vs. ZT18) impacts on the LPS-induction of p65 and
p-IjB in the SCN. For p65 there was a main effect of treatment, but not a time x treatment interaction; for p-IjB, there was neither a main effect of treatment,
nor a treatment x time interaction (N = 4–5 for each group per time point).
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mortality associated with LPS-induced septic shock was coordinated
with the whole-body response of NF-jB transcriptional activity in
response to the LPS treatment. Further, such an effect could be
understood in the light of CLOCK acting as a positive regulator of
NF-jB in HEK cells, and NF-jB activity in liver and embryonic
fibroblast being down regulated in clock/ mice. Similarly, cry
knockout mice show elevated constitutive NF-jB activity in fibrob-
lasts via elevated phosphorylation of IjB and IKK (Narasimamurthy
et al., 2012). Potential for NF-jB to alter circadian clock gene
expression is indicated by the finding that RelB suppresses circadian
regulation of transcription by interacting with BMAL1 in fibroblasts;
further, relb/ fibroblasts have markedly altered circadian gene
expression profiles (Bellet et al., 2012). In intestinal epithelial cells,
NF-jB-mediated transcription shows diurnal rhythmicity driven by
the microbiome (Mukherji et al., 2013). Such findings appear to be
in agreement with our results from serum-shocked fibroblasts dis-
playing circadian rhythmicity in nuclear p65 accumulation. The per-
sistence of rhythmic p65-dependent transcription in sham-shocked
fibroblasts may be a result of the serum free conditions used for the
sham-shock acting on another component of the NF-jB system,
such as P50. These results, together with previous findings, do sug-
gest that NF-jB signalling plays a role in circadian timing in periph-
eral cells, and as such indicate the possibility that NF-jB could play
a role in regulating clock processes in the CNS.
A small number of other studies have assessed NF-jB function in
components of the circadian system. In the rat pineal gland it has
been reported that NF-jB activity shows a sharp decrease at the
onset of darkness in a light : dark cycle, and this decrease is driven
by noradrenergic sympathetic input to the pineal (Cecon et al.,
2010; Villela et al., 2014). In the hamster SCN, Marpegan et al.
(2004) showed that whilst the SCN showed evidence of active NF-
jB, there was no circadian or diurnal variation in the levels of
nuclear p65 from SCN lysates. However, this study did report that
report that treatment with PDTC attenuated photically-induced phase
advances (but not delays). Our present results are in agreement with
some of these previous findings, in that we find no evidence for
Fig. 6. Low-dose LPS treatment’s impact on NF-jB in the SCN. (A) Treatment with 100 lg/kg LPS i.p. at CT15 induces a modest phase-delay compared to saline
control treatment (N = 6). (B) SCN tissue examined 4 h after 100 lg/kg LPS treatment at CT15 showed that LPS treatment resulted in upregulation of p65 compared
to saline control (N = 6 for each group; * = P < 0.05), but (C) did not result in any significant change in p-IjB SCN expression. (D) LPS treatment also upregulated
SCN expression of c-Fos, but (E) did not significantly alter the expression of the clock gene product PER1. [Colour figure can be viewed at wileyonlinelibrary.com].
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rhythmic expression of any of the NF-jB components we examined
in the SCN, nor do we find that ongoing treatment with PDTC alters
either diurnal or circadian rhythms in the mouse. Further, PDTC
treatment did not impact on the day/night rhythm in PER1 expres-
sion in SCN (although there is the caveat that only two time-points
were examined in this experiment). Our experiments in vitro further
failed in large part to show any significant effect of inhibition of the
NF-jB pathway with either PDTC or sulfasalazine on PER2::LUC
rhythms, or using LPS as an activator of the NF-kB pathway via
TLR4. The effect of PDTC on mesor may reflect a mechanism
through which NF-jB is upregulated as a by-product of slice prepa-
ration and/or culture, and which impacts on the rhythm adjusted
mean level of PER2::luc expression. A lack of impact of LPS treat-
ment on PER2::LUC SCN rhythms has previously been reported by
Guenthner et al. (2009), and indicates that activation of NF-jB sig-
nalling via this mechanism does not impact on core clock processes.
Further, in phase-resetting experiment with 100 lg LPS at CT15,
we did not observe changes in PER1 after 4 h, although there may
be subsequent modulation that would be revealed at different time-
points. However, it is interesting to note that a previous study
demonstrated that TNF-a treatment, which would also be expected
to activate NF-jB, alters PER2::LUC rhythms in SCN astrocytes
(Duhart et al., 2013). Such an effect may be confined to glial cells,
and differences between LPS and TNF-a treatment effects may also
Fig. 7. Effects of NF-jB inhibition and activation on PER2::luc rhythms in the SCN in vitro. (A) Treatment of SCN slices with PDTC (20 lM; N = 21) eli-
cited no statistically significant changes compared to vehicle treated slices (N = 20) in PER2::luc rhythm period, acrophase, or amplitude, although there was a
significant increase in mesor in PDTC treated slices (** = P < 0.01). (B) Similarly, in slices treated with the NF-jB inhibitor sulfasalazine (10 lM; N = 7 for
both treated and vehicle groups), there was no changes in period acrophase, amplitude or mesor. (C) Slices were treated LPS (100 ng/mL), as an activator of
NF-kB (N = 8 for LPS and vehicle groups). LPS treatment was found to have no significant effects on PER2::Luc period, acrophase, amplitude or mesor. (D)
Bioluminescence was monitored in SCN slices from nfkb::luc mice (N = 14). Raw bioluminescence traces from four slices are shown, as are detrended and
smoothed data from the same slices (E), indicating that there is no evidence for any circadian modulation of nfkb::luc expression. (F) As a positive control,
nfkb::luc slices were cultured in the presence of LPS. In these slices (N = 7), nfkb::luc signal was significantly stronger than in control slices
(*** = P < 0.001). [Colour figure can be viewed at wileyonlinelibrary.com].
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reflect differing signal transduction mechanisms. Finally in our
experiments with nf-kb::luc SCN slice we observed no evidence for
circadian regulation of NF-kB driven transcription in the SCN,
although the nf-kb::luc signal was responsive to treatment with LPS.
These results are in contrast to findings from Drosophila neurons,
which show circadian rhythms in NF-jB driven luciferase activity
(Tanenhaus et al., 2012). There is the possibility that NF-jB driven
transcriptional activity may show circadian rhythms in glial cells
rather than neurones, and future work may address this question in
SCN derived astrocytes and microglia.
We further find no evidence to support a role for NF-jB signalling
in photic resetting of the clock. In other paradigms, NF-jB has been
postulated to be regulated by glutamatergic transmission and to be
involved in synaptic plasticity (Snow et al., 2014). Given that the
major route of transmission of photic information to the SCN is the
mono-synaptic glutamatergic projections of the RHT (Abrahamson &
Moore, 2001), it seems plausible that NF-jB signalling might be
involved in photic resetting. However, we find no evidence to support
this contention. Light-pulse did not impact on p65 in the SCN at either
the delay or the advance portion of the photic phase-response curve,
treatment with PDTC did not attenuate photically-induced phase
delays or advances, and PDTC treatment also did not impact on photic
induction of the IEGs c-Fos and ARC in the SCN. These findings dif-
fer from those of Marpegan et al. (2004) who report that i.c.v. injec-
tion of PDTC significantly attenuates photic phase advances in the
hamster. The reason for the discrepancy between these finding is not
clear; the modality of PDTC administration (i.p. vs. i.c.v) may be a
factor, although several studies have demonstrated CNS effects of i.p.
administered PDTC at the concentration used and in the timescale also
that is relevant for the current experiments (e.g. Madrigal et al., 2001;
Shen et al., 2003). There may be a species difference between ham-
sters and mice, for example in the magnitude of the photic phase
advances (larger in hamsters) and differences in the photic phase
response curves. Further, there is always a concern around specificity
when using pharmacological inhibitors of biochemical pathways.
PDTC has been used extensively in the past, and is a potent inhibitor
of NF-jB activation (Gupta et al., 2010). However, it is also an anti-
oxidant, and also as an inhibitor of NF-jB signalling, suppresses tran-
scription of inflammation-driven products, such as inducible nitric
oxide synthase, and as such there is potential for off-target or indirect
effects. However, given that we do not see evidence for nuclear
translocation of p65 in the SCN following light pulses, we propose
that PDTC does not attenuate phase shifts in the mouse because the
NF-jB pathway is simply not involved in photic phase shifting in the
mouse.
Given that NF-jB has been implicated in hypothalamic dysfunc-
tion with ageing (e.g. Zhang et al., 2013), that circadian rhythms
are impacted by age (Popa-Wagner et al., 2017), and that the SCN
shows evidence of neuroinflammation during normal ageing (Deng
et al., 2010), we examined whether NF-kB might play a role in the
function of the SCN from older animals. Mice of the age used in
the current study have previously been demonstrated to exhibit
abnormalities in the circadian system (e.g. Wyse and Coogan,
2010). The current data do not suggest that ageing is associated with
elevation of basal p65 expression in the SCN, or with changes in
the reactivity of the SCN to peripheral LPS treatment. In vitro find-
ings that PDTC treatment does increase PER2::LUC rhythm ampli-
tude suggests that NF-jB could be implicated in the diminution of
rhythm robustness that has been described in a number of models of
healthy ageing (Popa-Wagner et al., 2017), and the seeming discrep-
ancy between in vivo and in vitro findings may be explained by acti-
vation of the NF-jB pathway as part of an inflammatory response
during slice preparation and culture (Schneider et al., 1998; Humpel,
2015). It will be of interest to examine if SCN NF-jB signalling is
implicated in circadian dysfunction in models of diseases such as
Alzheimer’s disease, in which neuroinflammation is strongly impli-
cated (Da Mesquita et al., 2016), and in which there are also
marked circadian changes (Coogan et al., 2013).
It may be surprising that given the previously postulated roles of
NF-jB signalling in neurophysiological processes, such as synaptic
plasticity (Salles et al., 2014), that there appears to be so little a role
for NF-jB in regulating SCN function, especially when findings
from peripheral cell types indicate clear molecular mechanisms
through which such regulation could occur. However, in the light of
the current controversy over whether young, adult, healthy neurones
express NF-jB under basal conditions (Listwak et al., 2013; Zhang
et al., 2013), and findings that a number of antibodies previously
used in the investigation of neuronal functions of NF-jB may not
be reliable in terms of specificity (Herkenham et al., 2011; Slotta
et al., 2014), a relatively straightforward explanation for the current
results may be that SCN neurons simply do not express appreciable
levels of NF-jB activity in neurons, and effects which are observed
(e.g. following LPS treatment) may be associated with glial cells (as
previously postulated by Leone et al., 2006). It may be that NF-jB
plays little role in neuronal function in the SCN under basal condi-
tions, but that NF-jB signalling is involved in SCN glial function.
Astrocytes and microglia have previously been demonstrated to
express molecular circadian rhythms (Fonken et al., 2015; Prolo
et al., 2005), and as such glia have previously been postulated as an
interface for circadian-immune signalling (Leone et al., 2006). Our
current findings for involvement of NF-jB signalling in the SCN
following immune challenge is congruent with this hypothesis. It
will be of interest for future studies to directly address the role of
NF-jB signalling in SCN glial response to immune activation and
neuroinflammation with careful cellular and biochemical analysis.
In summary, we believe that our current experimental approach
has been comprehensive, and that our findings are consistent in fail-
ing to demonstrate substantive evidence for involvement of NF-jB
signalling in the SCN circadian clock under basal conditions, whilst
also indicating that NF-kB signalling may be important in circadian-
immune dialogue in the master SCN clock.
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